Search
healthcare › ... › endoscopy
… All patients will be informed at the time of their visit of the potential need for an endoscopic evaluation, …
healthcare › ... › prosthetic-replacement-of-the-ocular-surface-ecosystem-prose
… Fellow to assess candidacy. PROSE treatment (5-10 day-long visits). Periodic follow-up visits as required during the first 6 months. Annual …
research › research-centers › tailor
… or contamination. The TAILOR team strives to provide: Safe, targeted antibacterial products that are thoroughly …
healthcare › clinical-trials › h-45197
… B-59: Neoadjuvant Chemotherapy with Atezolizumab or Placebo for Triple Negative Breast Cancer …
healthcare › clinical-trials › h-48193
… Placebo-controlled Trial to evaluate Tavapadon for PD in Levodopa treatment adults with motor fluctuations. … A trial to evaluate Tavapadon for Parkinson's disease in Levodopa treatment adults with …
news › baylor-college-medicines-center-space-medicine
… its renowned research and education programs in the Center for Space Medicine to include cutting-edge aerospace medicine for commercial space missions. “We are thrilled about this new … company, to provide medical services to ensure health and safety for the passengers and pilots on board Virgin …
healthcare › clinical-trials › h-45009
… Use of Natural Language Processing (NLP) for the detection of patients with immunological dysfunction …
healthcare › clinical-trials › h-44783
… neurocognitive testing and neuropsychological testing in combination to identify patients with mild traumatic brain … HEAD injury serum markers and multi-modalities for assessing response to trauma (HeadSMART II) …
news › baylor-and-rice-receive-2-3-million-to-develop-antibody-therapy-for-metastatic-breast-cancer
… has metastasized to bone. “Current treatments work well for ER+ breast cancer, but 20-40% of survivors later … a McNair Scholar at Baylor and a member of the Dan L Duncan Comprehensive Cancer Center. To address this problem, the … Activity at the U.S. Army Medical Research and Development Command, in the amount of $2.3 million through the Breast …
news › understanding-the-path-from-genetic-changes-to-parkinsons-disease-opens-possibilities-for-early-diagnosis
… The findings, published in the journal Brain , bring forward the possibility of identifying people at risk before … the symptoms. “Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer's disease, … onset and progression. The researchers focused on a common Parkinson’s risk gene called SPTSSB, which helps …